TermID Term Enrichment logP Genes in Term Target Genes in Term Fraction of Targets in Term Total Target Genes Total Genes Entrez Gene IDs Gene Symbols WP35 G Protein Signaling Pathways 4.09183750469427e-07 -14.7091015141427 95 7 0.25 28 5310 5578,5142,114,5567,3708,5136,5576 PRKCA,PDE4B,ADCY8,PRKACB,ITPR1,PDE1A,PRKAR2A WP536 Calcium Regulation in the Cardiac Cell 6.81507499498271e-07 -14.1989585814709 151 8 0.285714285714286 28 5310 3708,817,774,5567,5576,6262,114,5578 ITPR1,CAMK2D,CACNA1B,PRKACB,PRKAR2A,RYR2,ADCY8,PRKCA WP289 Myometrial Relaxation and Contraction Pathways 9.64270756149981e-07 -13.8518937143962 158 8 0.285714285714286 28 5310 6262,5567,5576,5578,114,3708,5142,817 RYR2,PRKACB,PRKAR2A,PRKCA,ADCY8,ITPR1,PDE4B,CAMK2D WP3679 Cell-type Dependent Selectivity of CCK2R Signaling 3.62625151214516e-05 -10.2247259915171 13 3 0.107142857142857 28 5310 6262,3708,23236 RYR2,ITPR1,PLCB1 WP2636 Common Pathways Underlying Drug Addiction 6.03482784096928e-05 -9.71537813759328 42 4 0.142857142857143 28 5310 5567,2892,114,5578 PRKACB,GRIA3,ADCY8,PRKCA WP2012 miRs in Muscle Cell Differentiation 0.000834647325573319 -7.08850128691731 36 3 0.107142857142857 28 5310 5576,5567,5578 PRKAR2A,PRKACB,PRKCA WP2795 Cardiac Hypertrophic Response 0.00317635243287739 -5.75202177422302 57 3 0.107142857142857 28 5310 817,5578,2932 CAMK2D,PRKCA,GSK3B WP3915 Angiopoietin Like Protein 8 Regulatory Pathway 0.00470144390989304 -5.35988560257609 132 4 0.142857142857143 28 5310 50488,2932,867,6256 MINK1,GSK3B,CBL,RXRA WP732 Serotonin Receptor 2 and ELK-SRF/GATA4 signaling 0.00480460752279079 -5.33817992089683 20 2 0.0714285714285714 28 5310 3708,5923 ITPR1,RASGRF1 WP2059 Alzheimers Disease 0.00704677672036916 -4.95518496949154 148 4 0.142857142857143 28 5310 23236,487,2932,3708 PLCB1,ATP2A1,GSK3B,ITPR1 WP481 Insulin Signaling 0.00944612034230802 -4.66215116756099 161 4 0.142857142857143 28 5310 50488,2932,867,5578 MINK1,GSK3B,CBL,PRKCA WP2583 T-Cell Receptor and Co-stimulatory Signaling 0.00997063588297369 -4.60811091740595 29 2 0.0714285714285714 28 5310 5578,2932 PRKCA,GSK3B WP2855 Dopaminergic Neurogenesis 0.0106481982800946 -4.54236457671648 30 2 0.0714285714285714 28 5310 4929,6571 NR4A2,SLC18A2 WP2355 Corticotropin-releasing hormone signaling pathway 0.0124126860653355 -4.38903625956525 93 3 0.107142857142857 28 5310 5578,4929,2932 PRKCA,NR4A2,GSK3B WP2197 Endothelin Pathways 0.012799510307831 -4.3583483659891 33 2 0.0714285714285714 28 5310 23236,5578 PLCB1,PRKCA WP3298 Melatonin metabolism and effects 0.0151243309344219 -4.19145051178436 36 2 0.0714285714285714 28 5310 5578,2932 PRKCA,GSK3B WP170 Nuclear Receptors 0.0176170696173963 -4.03888698232806 39 2 0.0714285714285714 28 5310 4929,6256 NR4A2,RXRA WP399 Wnt Signaling Pathway and Pluripotency 0.0176317129586209 -4.03805612571419 106 3 0.107142857142857 28 5310 5578,2932,27022 PRKCA,GSK3B,FOXD3 WP2267 Synaptic Vesicle Pathway 0.0302283388201394 -3.49897542306885 52 2 0.0714285714285714 28 5310 6571,774 SLC18A2,CACNA1B WP363 Wnt Signaling Pathway Netpath 0.0313126220058456 -3.46373400375038 53 2 0.0714285714285714 28 5310 5578,2932 PRKCA,GSK3B WP673 ErbB Signaling Pathway 0.0324122910310399 -3.42921757531007 54 2 0.0714285714285714 28 5310 5578,2932 PRKCA,GSK3B WP2380 Brain-Derived Neurotrophic Factor (BDNF) signaling pathway 0.0390027727080153 -3.24412254030231 144 3 0.107142857142857 28 5310 5923,2892,2932 RASGRF1,GRIA3,GSK3B WP304 Kit receptor signaling pathway 0.0393234347668272 -3.23593463332638 60 2 0.0714285714285714 28 5310 5578,867 PRKCA,CBL WP3863 T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection 0.0417422424495547 -3.17624165454152 62 2 0.0714285714285714 28 5310 2932,867 GSK3B,CBL WP3680 Association Between Physico-Chemical Features and Toxicity Associated Pathways 0.0493249186479605 -3.00932587638125 68 2 0.0714285714285714 28 5310 2932,867 GSK3B,CBL WP1403 AMP-activated Protein Kinase (AMPK) Signaling 0.0493249186479605 -3.00932587638125 68 2 0.0714285714285714 28 5310 23236,5567 PLCB1,PRKACB WP1531 Vitamin D Metabolism 0.0515395534231087 -2.96540573846157 10 1 0.0357142857142857 28 5310 6256 RXRA WP2874 Liver X Receptor Pathway 0.0515395534231087 -2.96540573846157 10 1 0.0357142857142857 28 5310 6256 RXRA WP428 Wnt Signaling Pathway 0.0519568345008943 -2.95734201088131 70 2 0.0714285714285714 28 5310 2932,5578 GSK3B,PRKCA WP706 Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 0.052282914192208 -2.95108564977108 162 3 0.107142857142857 28 5310 5576,5567,6262 PRKAR2A,PRKACB,RYR2 WP437 EGF/EGFR Signaling Pathway 0.052282914192208 -2.95108564977108 162 3 0.107142857142857 28 5310 867,5578,51196 CBL,PRKCA,PLCE1 WP2037 Prolactin Signaling Pathway 0.0601477549483927 -2.81095116147426 76 2 0.0714285714285714 28 5310 867,2932 CBL,GSK3B WP2118 Arrhythmogenic Right Ventricular Cardiomyopathy 0.0601477549483927 -2.81095116147426 76 2 0.0714285714285714 28 5310 6262,785 RYR2,CACNB4 WP1559 TFs Regulate miRNAs related to cardiac hypertrophy 0.0615354910931048 -2.78814117967781 12 1 0.0357142857142857 28 5310 5923 RASGRF1 WP1991 SRF and miRs in Smooth Muscle Differentiation and Proliferation 0.0664952884212076 -2.71062418463927 13 1 0.0357142857142857 28 5310 817 CAMK2D WP2261 Signaling Pathways in Glioblastoma 0.0702285110517789 -2.6560009100643 83 2 0.0714285714285714 28 5310 867,5578 CBL,PRKCA WP2436 Dopamine metabolism 0.0714298045490282 -2.63904006607788 14 1 0.0357142857142857 28 5310 5567 PRKACB WP3 Transcriptional activation by NRF2 0.0763391635893571 -2.57256918811285 15 1 0.0357142857142857 28 5310 5578 PRKCA WP69 T-Cell antigen Receptor (TCR) Signaling Pathway 0.0823796093406303 -2.49641733214823 91 2 0.0714285714285714 28 5310 867,3708 CBL,ITPR1 WP3664 Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds 0.0909175305549459 -2.39780244100297 18 1 0.0357142857142857 28 5310 2932 GSK3B WP23 B Cell Receptor Signaling Pathway 0.0935097731498463 -2.36968932248312 98 2 0.0714285714285714 28 5310 2932,867 GSK3B,CBL WP2879 Farnesoid X Receptor Pathway 0.0957274907094497 -2.34624976253237 19 1 0.0357142857142857 28 5310 6256 RXRA WP1544 MicroRNAs in cardiomyocyte hypertrophy 0.100060142360557 -2.30198385017117 102 2 0.0714285714285714 28 5310 2932,817 GSK3B,CAMK2D WP2064 Neural Crest Differentiation 0.100060142360557 -2.30198385017117 102 2 0.0714285714285714 28 5310 27022,2932 FOXD3,GSK3B WP1602 Nicotine Activity on Dopaminergic Neurons 0.105273895906705 -2.25118979269557 21 1 0.0357142857142857 28 5310 6571 SLC18A2 WP3872 Regulation of Apoptosis by Parathyroid Hormone-related Protein 0.110010581653127 -2.20717872096973 22 1 0.0357142857142857 28 5310 2932 GSK3B WP167 Eicosanoid Synthesis 0.110010581653127 -2.20717872096973 22 1 0.0357142857142857 28 5310 1800 DPEP1 WP3599 Transcription factor regulation in adipogenesis 0.110010581653127 -2.20717872096973 22 1 0.0357142857142857 28 5310 6256 RXRA WP3658 Wnt/beta-catenin Signaling Pathway in Leukemia 0.11941151694786 -2.12517962582555 24 1 0.0357142857142857 28 5310 2932 GSK3B WP1528 Physiological and Pathological Hypertrophy of the Heart 0.12407600380606 -2.08686096722453 25 1 0.0357142857142857 28 5310 817 CAMK2D WP205 IL-7 Signaling Pathway 0.12407600380606 -2.08686096722453 25 1 0.0357142857142857 28 5310 2932 GSK3B WP2878 PPAR Alpha Pathway 0.128716660739137 -2.05014171868596 26 1 0.0357142857142857 28 5310 6256 RXRA WP26 Signal Transduction of S1P Receptor 0.128716660739137 -2.05014171868596 26 1 0.0357142857142857 28 5310 23236 PLCB1 WP2035 Follicle Stimulating Hormone (FSH) signaling pathway 0.133333605003251 -2.01490098301996 27 1 0.0357142857142857 28 5310 5578 PRKCA WP3844 PI3K-AKT-mTOR signaling pathway and therapeutic opportunities 0.147043326042185 -1.91702800064837 30 1 0.0357142857142857 28 5310 2932 GSK3B WP3850 Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling 0.151566581130672 -1.88673027116513 31 1 0.0357142857142857 28 5310 2932 GSK3B WP2112 IL17 signaling pathway 0.151566581130672 -1.88673027116513 31 1 0.0357142857142857 28 5310 2932 GSK3B WP2875 Constitutive Androstane Receptor Pathway 0.156066701555565 -1.85747178904221 32 1 0.0357142857142857 28 5310 6256 RXRA WP400 p38 MAPK Signaling Pathway 0.164997993733793 -1.80182196434462 34 1 0.0357142857142857 28 5310 5923 RASGRF1 WP244 Alpha 6 Beta 4 signaling pathway 0.169429391795131 -1.77531900653036 35 1 0.0357142857142857 28 5310 5578 PRKCA WP2884 NRF2 pathway 0.173305957309004 -1.75269670715029 143 2 0.0714285714285714 28 5310 6256,25800 RXRA,SLC39A6 WP500 Glycogen Metabolism 0.1738381078193 -1.74963082770376 36 1 0.0357142857142857 28 5310 2932 GSK3B WP1471 Target Of Rapamycin (TOR) Signaling 0.178224253627269 -1.72471266979886 37 1 0.0357142857142857 28 5310 5578 PRKCA WP3529 Zinc homeostasis 0.178224253627269 -1.72471266979886 37 1 0.0357142857142857 28 5310 25800 SLC39A6 WP127 IL-5 Signaling Pathway 0.19124837998531 -1.65418227697641 40 1 0.0357142857142857 28 5310 2932 GSK3B WP49 IL-2 Signaling Pathway 0.199820306065774 -1.61033678597103 42 1 0.0357142857142857 28 5310 867 CBL WP2036 TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway 0.199820306065774 -1.61033678597103 42 1 0.0357142857142857 28 5310 2932 GSK3B WP364 IL-6 signaling pathway 0.204073349239822 -1.5892757946652 43 1 0.0357142857142857 28 5310 2932 GSK3B WP716 Vitamin A and Carotenoid Metabolism 0.208304590212431 -1.5687538944125 44 1 0.0357142857142857 28 5310 6256 RXRA WP3878 ATM Signaling Network in Development and Disease 0.216702095645361 -1.52923169976503 46 1 0.0357142857142857 28 5310 5923 RASGRF1 WP382 MAPK Signaling Pathway 0.225416978275763 -1.48980335512114 170 2 0.0714285714285714 28 5310 50488,22808 MINK1,MRAS WP286 IL-3 Signaling Pathway 0.229137511881588 -1.47343296708313 49 1 0.0357142857142857 28 5310 867 CBL WP2406 Cardiac Progenitor Differentiation 0.245422253961985 -1.40477506637524 53 1 0.0357142857142857 28 5310 2932 GSK3B WP3286 Copper homeostasis 0.249441309867268 -1.38853162245463 54 1 0.0357142857142857 28 5310 2932 GSK3B WP585 Interferon type I signaling pathways 0.253439719934205 -1.37262927541428 55 1 0.0357142857142857 28 5310 867 CBL WP2272 Pathogenic Escherichia coli infection 0.253439719934205 -1.37262927541428 55 1 0.0357142857142857 28 5310 5578 PRKCA WP2018 RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway 0.253439719934205 -1.37262927541428 55 1 0.0357142857142857 28 5310 867 CBL WP395 IL-4 Signaling Pathway 0.253439719934205 -1.37262927541428 55 1 0.0357142857142857 28 5310 867 CBL WP3527 Preimplantation Embryo 0.273125640992506 -1.29782336625172 60 1 0.0357142857142857 28 5310 11189 CELF3 WP2377 Integrated Pancreatic Cancer Pathway 0.278740284344495 -1.27747481118476 197 2 0.0714285714285714 28 5310 6256,5578 RXRA,PRKCA WP61 Notch Signaling Pathway 0.280859026569097 -1.26990242034181 62 1 0.0357142857142857 28 5310 2932 GSK3B WP2324 AGE/RAGE pathway 0.296088475435262 -1.21709696582332 66 1 0.0357142857142857 28 5310 5578 PRKCA WP2374 Oncostatin M Signaling Pathway 0.296088475435262 -1.21709696582332 66 1 0.0357142857142857 28 5310 5578 PRKCA WP3594 Circadian rythm related genes 0.298546906565117 -1.20882821757316 207 2 0.0714285714285714 28 5310 2932,3751 GSK3B,KCND2 WP2032 Human Thyroid Stimulating Hormone (TSH) signaling pathway 0.303586100684076 -1.19209001618168 68 1 0.0357142857142857 28 5310 23236 PLCB1 WP2572 Primary Focal Segmental Glomerulosclerosis FSGS 0.325619796067396 -1.12202484796913 74 1 0.0357142857142857 28 5310 51196 PLCE1 WP2034 Leptin signaling pathway 0.33281381867934 -1.10017204842314 76 1 0.0357142857142857 28 5310 2932 GSK3B WP138 Androgen receptor signaling pathway 0.381139736530213 -0.964589208549887 90 1 0.0357142857142857 28 5310 2932 GSK3B WP179 Cell Cycle 0.429168263420759 -0.845906214527218 105 1 0.0357142857142857 28 5310 2932 GSK3B WP615 Senescence and Autophagy in Cancer 0.432239020121061 -0.838776556427747 106 1 0.0357142857142857 28 5310 2932 GSK3B WP710 DNA Damage Response (only ATM dependent) 0.456238159244931 -0.784740326762081 114 1 0.0357142857142857 28 5310 2932 GSK3B WP2431 Spinal Cord Injury 0.47073764007013 -0.753454367615099 119 1 0.0357142857142857 28 5310 5578 PRKCA WP236 Adipogenesis 0.504031410325312 -0.685116690778676 131 1 0.0357142857142857 28 5310 6256 RXRA WP366 TGF-beta Signaling Pathway 0.509380286260289 -0.674560417106551 133 1 0.0357142857142857 28 5310 5576 PRKAR2A WP51 Regulation of Actin Cytoskeleton 0.550214167034595 -0.597447681941671 149 1 0.0357142857142857 28 5310 22808 MRAS WP306 Focal Adhesion 0.65017688669603 -0.430510819735518 195 1 0.0357142857142857 28 5310 2932 GSK3B WP1423 Ganglio Sphingolipid Metabolism 0.999999999988151 -1.18493865704768e-11 13 0 0 28 5310 WP3871 Valproic acid pathway 0.999999999988151 -1.18493865704768e-11 13 0 0 28 5310 WP3892 Development of pulmonary dendritic cells and macrophage subsets 0.999999999988151 -1.18493865704768e-11 13 0 0 28 5310 WP186 Homologous recombination 0.999999999988151 -1.18493865704768e-11 13 0 0 28 5310 WP2881 Estrogen Receptor Pathway 0.999999999988151 -1.18493865704768e-11 13 0 0 28 5310 WP1434 Osteopontin Signaling 0.999999999988151 -1.18493865704768e-11 13 0 0 28 5310 WP3876 BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation 0.999999999988151 -1.18493865704768e-11 13 0 0 28 5310 WP3585 Cytosine methylation 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP288 NLR Proteins 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP3674 Tgif disruption of Shh signaling 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP3297 EV release from cardiac cells and their functional effects 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP2942 DDX1 as a regulatory component of the Drosha microprocessor 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP3300 Dual hijack model of Vif in HIV infection 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP696 Benzo(a)pyrene metabolism 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP531 Mismatch repair 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP561 Heme Biosynthesis 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP3875 ATR Signaling 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP3593 miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma 0.999999999988205 -1.1794997020032e-11 9 0 0 28 5310 WP2359 Parkin-Ubiquitin Proteasomal System pathway 0.999999999988956 -1.10439808183925e-11 70 0 0 28 5310 WP195 IL-1 signaling pathway 0.999999999990433 -9.56710237524666e-12 57 0 0 28 5310 WP383 Striated Muscle Contraction 0.999999999990749 -9.25063642226364e-12 38 0 0 28 5310 WP2526 PDGF Pathway 0.999999999990749 -9.25063642226364e-12 38 0 0 28 5310 WP2447 Amyotrophic lateral sclerosis (ALS) 0.999999999990749 -9.25063642226364e-12 38 0 0 28 5310 WP2029 Cell Differentiation - Index 0.999999999990749 -9.25063642226364e-12 38 0 0 28 5310 WP2637 Structural Pathway of Interleukin 1 (IL-1) 0.999999999990927 -9.07346396141502e-12 50 0 0 28 5310 WP1545 miRNAs involved in DNA damage response 0.999999999990927 -9.07346396141502e-12 50 0 0 28 5310 WP558 Complement and Coagulation Cascades 0.999999999992738 -7.26245899428103e-12 60 0 0 28 5310 WP2597 Secretion of Hydrochloric Acid in Parietal Cells 0.999999999993297 -6.70253512974741e-12 5 0 0 28 5310 WP688 Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) 0.999999999993297 -6.70253512974741e-12 5 0 0 28 5310 WP2868 TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer 0.999999999993297 -6.70253512974741e-12 5 0 0 28 5310 WP311 Synthesis and Degradation of Ketone Bodies 0.999999999993297 -6.70253512974741e-12 5 0 0 28 5310 WP2542 Sulindac Metabolic Pathway 0.999999999993297 -6.70253512974741e-12 5 0 0 28 5310 WP3596 miR-517 relationship with ARCN1 and USP1 0.999999999993297 -6.70253512974741e-12 5 0 0 28 5310 WP698 Glucuronidation 0.999999999993429 -6.57143281177104e-12 26 0 0 28 5310 WP325 Triacylglyceride Synthesis 0.999999999993429 -6.57143281177104e-12 26 0 0 28 5310 WP581 EPO Receptor Signaling 0.999999999993429 -6.57143281177104e-12 26 0 0 28 5310 WP530 Cytokines and Inflammatory Response 0.999999999993429 -6.57143281177104e-12 26 0 0 28 5310 WP1601 Fluoropyrimidine Activity 0.999999999994235 -5.76497853292916e-12 34 0 0 28 5310 WP143 Fatty Acid Beta Oxidation 0.999999999994235 -5.76497853292916e-12 34 0 0 28 5310 WP313 Signaling of Hepatocyte Growth Factor Receptor 0.999999999994235 -5.76497853292916e-12 34 0 0 28 5310 WP477 Cytoplasmic Ribosomal Proteins 0.999999999994505 -5.49479413385568e-12 90 0 0 28 5310 WP3408 Evolocumab Mechanism 0.999999999994507 -5.49285960936527e-12 3 0 0 28 5310 WP2846 Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation 0.999999999994507 -5.49285960936527e-12 3 0 0 28 5310 WP2203 Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway 0.999999999994643 -5.3574104170933e-12 47 0 0 28 5310 WP2249 Metastatic brain tumor 0.999999999994915 -5.08538930945218e-12 28 0 0 28 5310 WP2361 Gastric Cancer Network 1 0.999999999994915 -5.08538930945218e-12 28 0 0 28 5310 WP497 Urea cycle and metabolism of amino groups 0.999999999995462 -4.53817729977499e-12 20 0 0 28 5310 WP1422 Sphingolipid Metabolism 0.999999999995462 -4.53817729977499e-12 20 0 0 28 5310 WP391 Mitochondrial Gene Expression 0.999999999995462 -4.53817729977499e-12 20 0 0 28 5310 WP516 Hypertrophy Model 0.999999999995462 -4.53817729977499e-12 20 0 0 28 5310 WP1742 TP53 Network 0.999999999995462 -4.53817729977499e-12 20 0 0 28 5310 WP3845 Canonical and Non-canonical Notch signaling 0.999999999995477 -4.52333261529178e-12 27 0 0 28 5310 WP2369 Histone Modifications 0.999999999996034 -3.96608109947251e-12 69 0 0 28 5310 WP176 Folate Metabolism 0.999999999996034 -3.96608109947251e-12 69 0 0 28 5310 WP707 DNA Damage Response 0.999999999996034 -3.96608109947251e-12 69 0 0 28 5310 WP3611 Photodynamic therapy-induced AP-1 survival signaling. 0.999999999996557 -3.4430416979358e-12 51 0 0 28 5310 WP3646 Hepatitis C and Hepatocellular Carcinoma 0.999999999996557 -3.4430416979358e-12 51 0 0 28 5310 WP2011 SREBF and miR33 in cholesterol and lipid homeostasis 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP384 Apoptosis Modulation by HSP70 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP3877 Simplified Depiction of MYD88 Distinct Input-Output Pathway 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP3287 Overview of nanoparticle effects 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP247 Small Ligand GPCRs 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP697 Estrogen metabolism 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP404 Nucleotide Metabolism 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP22 IL-9 Signaling Pathway 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP734 Serotonin Receptor 4/6/7 and NR3C Signaling 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP1992 TarBasePathway 0.999999999996893 -3.10677509280924e-12 19 0 0 28 5310 WP2253 Pilocytic astrocytoma 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP3302 eIF5A regulation in response to inhibition of the nuclear export system 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP3633 Caffeine and Theobromine metabolism 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP733 Serotonin Receptor 2 and STAT3 Signaling 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP2889 Oxytocin signaling 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP897 Androgen receptor signaling pathway 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP521 Amino acid conjugation of benzoic acid 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP1603 Nicotine Activity on Chromaffin Cells 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP1133 Androgen receptor signaling pathway 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP1941 Peroxisomal beta-oxidation of tetracosanoyl-CoA 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP690 Polyol Pathway 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP2491 Diclofenac Metabolic Pathway 0.999999999997034 -2.96627155398293e-12 4 0 0 28 5310 WP1530 miRNA Regulation of DNA Damage Response 0.999999999997442 -2.55831223113813e-12 93 0 0 28 5310 WP1539 Angiogenesis 0.999999999997569 -2.43121612403227e-12 24 0 0 28 5310 WP2509 Nanoparticle triggered autophagic cell death 0.999999999997569 -2.43121612403227e-12 24 0 0 28 5310 WP334 GPCRs, Class B Secretin-like 0.999999999997569 -2.43121612403227e-12 24 0 0 28 5310 WP262 EBV LMP1 signaling 0.999999999997569 -2.43121612403227e-12 24 0 0 28 5310 WP1604 Codeine and Morphine Metabolism 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP1589 Folate-Alcohol and Cancer Pathway 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP237 Glucocorticoid & Mineralcorticoid Metabolism 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP3655 Hypothetical Craniofacial Development Pathway 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP3635 Insulin signalling in human adipocytes (diabetic condition) 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP2485 NAD Biosynthesis II (from tryptophan) 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP3634 Insulin signalling in human adipocytes (normal condition) 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP3407 FTO Obesity Variant Mechanism 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP2338 miRNA Biogenesis 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP2276 Glial Cell Differentiation 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP136 Phase I biotransformations, non P450 0.999999999997616 -2.38369742939115e-12 8 0 0 28 5310 WP2848 Differentiation Pathway 0.999999999997747 -2.25336997102276e-12 48 0 0 28 5310 WP2849 Hematopoietic Stem Cell Differentiation 0.999999999997747 -2.25336997102276e-12 48 0 0 28 5310 WP2586 Aryl Hydrocarbon Receptor 0.999999999997747 -2.25336997102276e-12 48 0 0 28 5310 WP2873 Aryl Hydrocarbon Receptor Pathway 0.999999999997747 -2.25336997102276e-12 48 0 0 28 5310 WP2857 Mesodermal Commitment Pathway 0.999999999997928 -2.07189781748116e-12 155 0 0 28 5310 WP314 Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation 0.999999999997971 -2.02948255580197e-12 44 0 0 28 5310 WP2332 Interleukin-11 Signaling Pathway 0.999999999997971 -2.02948255580197e-12 44 0 0 28 5310 WP3651 Pathways Affected in Adenoid Cystic Carcinoma 0.999999999998155 -1.84521710462005e-12 66 0 0 28 5310 WP183 Proteasome Degradation 0.999999999998155 -1.84521710462005e-12 66 0 0 28 5310 WP410 Diurnally Regulated Genes with Circadian Orthologs 0.999999999998623 -1.37663479424936e-12 49 0 0 28 5310 WP534 Glycolysis and Gluconeogenesis 0.999999999998623 -1.37663479424936e-12 49 0 0 28 5310 WP524 G13 Signaling Pathway 0.999999999998702 -1.29804566454308e-12 40 0 0 28 5310 WP2516 ATM Signaling Pathway 0.999999999998702 -1.29804566454308e-12 40 0 0 28 5310 WP2371 Parkinsons Disease Pathway 0.999999999998973 -1.02671728801476e-12 83 0 0 28 5310 WP2507 Nanomaterial induced apoptosis 0.99999999999901 -9.89827692015443e-13 21 0 0 28 5310 WP3670 Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway 0.99999999999901 -9.89827692015443e-13 21 0 0 28 5310 WP2533 Glycerophospholipid Biosynthetic Pathway 0.99999999999901 -9.89827692015443e-13 21 0 0 28 5310 WP691 Tamoxifen metabolism 0.99999999999901 -9.89827692015443e-13 21 0 0 28 5310 WP1971 Integrated Cancer Pathway 0.999999999999016 -9.84106153138224e-13 46 0 0 28 5310 WP268 Notch Signaling Pathway 0.999999999999016 -9.84106153138224e-13 46 0 0 28 5310 WP465 Tryptophan metabolism 0.999999999999016 -9.84106153138224e-13 46 0 0 28 5310 WP1591 Heart Development 0.999999999999016 -9.84106153138224e-13 46 0 0 28 5310 WP28 Selenium Metabolism and Selenoproteins 0.999999999999016 -9.84106153138224e-13 46 0 0 28 5310 WP408 Oxidative Stress 0.999999999999041 -9.59107561740838e-13 31 0 0 28 5310 WP1425 Bone Morphogenic Protein (BMP) Signalling and Regulation 0.99999999999927 -7.2978406736944e-13 12 0 0 28 5310 WP2007 Iron metabolism in placenta 0.99999999999927 -7.2978406736944e-13 12 0 0 28 5310 WP3672 LncRNA-mediated mechanisms of therapeutic resistance 0.99999999999927 -7.2978406736944e-13 12 0 0 28 5310 WP106 Alanine and aspartate metabolism 0.99999999999927 -7.2978406736944e-13 12 0 0 28 5310 WP3301 MFAP5-mediated ovarian cancer cell motility and invasiveness 0.99999999999927 -7.2978406736944e-13 12 0 0 28 5310 WP2290 RalA downstream regulated genes 0.99999999999927 -7.2978406736944e-13 12 0 0 28 5310 WP3849 MAPK and NFkB Signalling Pathways Inhibited by Yersinia YopJ 0.99999999999927 -7.2978406736944e-13 12 0 0 28 5310 WP3925 Amino Acid metabolism 0.99999999999997 -2.96000995389583e-14 91 0 0 28 5310 WP3617 Photodynamic therapy-induced NF-kB survival signaling 0.999999999999982 -1.83500709414721e-14 35 0 0 28 5310 WP299 Nuclear Receptors in Lipid Metabolism and Toxicity 0.999999999999982 -1.83500709414721e-14 35 0 0 28 5310 WP58 Monoamine GPCRs 1.00000000000002 1.64119104877853e-14 33 0 0 28 5310 WP453 Inflammatory Response Pathway 1.00000000000002 1.64119104877853e-14 33 0 0 28 5310 WP430 Statin Pathway 1.00000000000002 1.64119104877853e-14 33 0 0 28 5310 WP3676 BDNF-TrkB Signaling 1.00000000000002 1.64119104877853e-14 33 0 0 28 5310 WP2363 Gastric Cancer Network 2 1.00000000000002 1.64119104877853e-14 33 0 0 28 5310 WP560 TGF-beta Receptor Signaling 1.00000000000019 1.90717997735659e-13 58 0 0 28 5310 WP111 Electron Transport Chain 1.00000000000025 2.52938681499649e-13 92 0 0 28 5310 WP2828 Bladder Cancer 1.00000000000035 3.4645484406721e-13 32 0 0 28 5310 WP727 Monoamine Transport 1.00000000000035 3.4645484406721e-13 32 0 0 28 5310 WP3858 Toll-like Receptor Signaling 1.00000000000035 3.4645484406721e-13 32 0 0 28 5310 WP3893 Development and heterogeneity of the ILC family 1.00000000000035 3.4645484406721e-13 32 0 0 28 5310 WP2525 Trans-sulfuration and one carbon metabolism 1.00000000000035 3.4645484406721e-13 32 0 0 28 5310 WP34 Ovarian Infertility Genes 1.00000000000035 3.4645484406721e-13 32 0 0 28 5310 WP411 mRNA Processing 1.00000000000038 3.76021703186381e-13 132 0 0 28 5310 WP474 Endochondral Ossification 1.00000000000043 4.34481459657631e-13 65 0 0 28 5310 WP254 Apoptosis 1.00000000000055 5.4827095308783e-13 86 0 0 28 5310 WP2816 Felbamate Metabolism 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP2943 Hypoxia-mediated EMT and Stemness 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP2366 Butyrate-induced histone acetylation 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP1311 Folic Acid Network 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP2866 mir34a and TGIF2 in osteoclastogenesis 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP2901 Gonadotropin-releasing hormone (GnRH) signaling 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP1438 Influenza A virus infection 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP1273 Folic Acid Network 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP2646 Lidocaine metabolism 1.00000000000059 5.94617501667016e-13 2 0 0 28 5310 WP712 Estrogen signaling pathway 1.00000000000078 7.79032462632333e-13 23 0 0 28 5310 WP3612 Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling 1.00000000000078 7.79032462632333e-13 23 0 0 28 5310 WP3865 RIG-I-like Receptor Signaling 1.00000000000103 1.02643449958352e-12 61 0 0 28 5310 WP699 Aflatoxin B1 metabolism 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP678 Arachidonate Epoxygenase / Epoxide Hydrolase 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP1995 Effects of Nitric Oxide 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP3595 mir-124 predicted interactions with cell cycle and differentiation 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP528 Acetylcholine Synthesis 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP1272 Selenium Micronutrient Network 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP438 Non-homologous end joining 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP2596 Gastric acid production 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP134 Pentose Phosphate Pathway 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP2805 RNA interference 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP3924 Hfe effect on hepcidin production 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP1310 Selenium Micronutrient Network 1.00000000000104 1.03827113327086e-12 7 0 0 28 5310 WP3879 4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression 1.00000000000106 1.06225320342345e-12 18 0 0 28 5310 WP3859 TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition 1.00000000000106 1.06225320342345e-12 18 0 0 28 5310 WP692 Sulfation Biotransformation Reaction 1.00000000000106 1.06225320342345e-12 18 0 0 28 5310 WP3413 NOTCH1 regulation of human endothelial cell calcification 1.00000000000106 1.06225320342345e-12 18 0 0 28 5310 WP272 Blood Clotting Cascade 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP3645 NAD+ biosynthetic pathways 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP100 Glutathione metabolism 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP545 Complement Activation 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP1424 Globo Sphingolipid Metabolism 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP357 Fatty Acid Biosynthesis 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP3657 Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP1584 Type II diabetes mellitus 1.00000000000116 1.1569922357437e-12 22 0 0 28 5310 WP2858 Ectoderm Differentiation 1.00000000000121 1.20686612286666e-12 143 0 0 28 5310 WP43 Oxidation by Cytochrome P450 1.00000000000162 1.62391196279076e-12 63 0 0 28 5310 WP3624 Lung fibrosis 1.00000000000162 1.62391196279076e-12 63 0 0 28 5310 WP2328 Allograft Rejection 1.00000000000165 1.64514308455744e-12 80 0 0 28 5310 WP3851 TLR4 Signaling and Tolerance 1.00000000000184 1.83925318867809e-12 30 0 0 28 5310 WP98 Prostaglandin Synthesis and Regulation 1.00000000000184 1.83925318867809e-12 30 0 0 28 5310 WP2870 Extracellular vesicle-mediated signaling in recipient cells 1.00000000000184 1.83925318867809e-12 30 0 0 28 5310 WP241 One Carbon Metabolism 1.00000000000184 1.83925318867809e-12 30 0 0 28 5310 WP129 Matrix Metalloproteinases 1.00000000000184 1.83925318867809e-12 30 0 0 28 5310 WP2536 Colchicine Metabolic Pathway 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP1 Statin Pathway 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP2190 One carbon donor 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP3627 Gut-Liver Indole Metabolism 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP3191 TSLP Signaling Pathway 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP108 Selenium metabolism/Selenoproteins 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP661 Glucose Homeostasis 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP188 Focal Adhesion 1.00000000000222 2.21551336304637e-12 1 0 0 28 5310 WP422 MAPK Cascade 1.00000000000223 2.22993288540501e-12 29 0 0 28 5310 WP2643 Nanoparticle-mediated activation of receptor signaling 1.00000000000223 2.22993288540501e-12 29 0 0 28 5310 WP3613 Photodynamic therapy-induced unfolded protein response 1.00000000000223 2.22993288540501e-12 29 0 0 28 5310 WP554 ACE Inhibitor Pathway 1.00000000000274 2.7358001873208e-12 17 0 0 28 5310 WP2916 Interactome of polycomb repressive complex 2 (PRC2) 1.00000000000274 2.7358001873208e-12 17 0 0 28 5310 WP368 Mitochondrial LC-Fatty Acid Beta-Oxidation 1.00000000000274 2.7358001873208e-12 17 0 0 28 5310 WP3678 Amplification and Expansion of Oncogenic Pathways as Metastatic Traits 1.00000000000274 2.7358001873208e-12 17 0 0 28 5310 WP3874 Canonical and Non-Canonical TGF-B signaling 1.00000000000274 2.7358001873208e-12 17 0 0 28 5310 WP2289 Drug Induction of Bile Acid Pathway 1.00000000000274 2.7358001873208e-12 17 0 0 28 5310 WP78 TCA Cycle 1.00000000000274 2.7358001873208e-12 17 0 0 28 5310 WP24 Peptide GPCRs 1.00000000000298 2.97719365052735e-12 74 0 0 28 5310 WP231 TNF alpha Signaling Pathway 1.00000000000309 3.09107782220872e-12 94 0 0 28 5310 WP1772 Apoptosis Modulation and Signaling 1.00000000000309 3.09107782220872e-12 94 0 0 28 5310 WP322 Osteoblast Signaling 1.00000000000321 3.21290288934033e-12 14 0 0 28 5310 WP229 Irinotecan Pathway 1.00000000000321 3.21290288934033e-12 14 0 0 28 5310 WP3853 ERK Pathway in Huntington's Disease 1.00000000000321 3.21290288934033e-12 14 0 0 28 5310 WP197 Cholesterol Biosynthesis 1.00000000000321 3.21385271732357e-12 15 0 0 28 5310 WP206 Fatty Acid Omega Oxidation 1.00000000000321 3.21385271732357e-12 15 0 0 28 5310 WP2435 Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis 1.00000000000321 3.21385271732357e-12 15 0 0 28 5310 WP1982 Sterol Regulatory Element-Binding Proteins (SREBP) signalling 1.0000000000035 3.50044481760931e-12 73 0 0 28 5310 WP694 Arylamine metabolism 1.00000000000427 4.26617174030832e-12 6 0 0 28 5310 WP1600 Nicotine Metabolism 1.00000000000427 4.26617174030832e-12 6 0 0 28 5310 WP1981 Thyroxine (Thyroid Hormone) Production 1.00000000000427 4.26617174030832e-12 6 0 0 28 5310 WP3891 Benzene metabolism 1.00000000000427 4.26617174030832e-12 6 0 0 28 5310 WP107 Translation Factors 1.00000000000427 4.27350618553122e-12 53 0 0 28 5310 WP1533 Vitamin B12 Metabolism 1.00000000000427 4.27350618553122e-12 53 0 0 28 5310 WP455 GPCRs, Class A Rhodopsin-like 1.00000000000429 4.28802641487919e-12 259 0 0 28 5310 WP2864 Apoptosis-related network due to altered Notch3 in ovarian cancer 1.00000000000444 4.44024464833681e-12 54 0 0 28 5310 WP623 Oxidative phosphorylation 1.00000000000444 4.44024464833681e-12 54 0 0 28 5310 WP3414 Initiation of transcription and translation elongation at the HIV-1 LTR 1.00000000000458 4.57586582698307e-12 37 0 0 28 5310 WP3614 Photodynamic therapy-induced HIF-1 survival signaling 1.00000000000458 4.57586582698307e-12 37 0 0 28 5310 WP619 Type II interferon signaling (IFNG) 1.00000000000458 4.57586582698307e-12 37 0 0 28 5310 WP117 GPCRs, Other 1.00000000000544 5.44470454527285e-12 95 0 0 28 5310 WP2113 Type III interferon signaling 1.00000000000606 6.05550892603656e-12 10 0 0 28 5310 WP496 Steroid Biosynthesis 1.00000000000606 6.05550892603656e-12 10 0 0 28 5310 WP3656 Interleukin-1 Induced Activation of NF-kappa-B 1.00000000000606 6.05550892603656e-12 10 0 0 28 5310 WP2333 Trans-sulfuration pathway 1.00000000000606 6.05550892603656e-12 10 0 0 28 5310 WP704 Methylation Pathways 1.00000000000606 6.05550892603656e-12 10 0 0 28 5310 WP3601 Composition of Lipid Particles 1.00000000000606 6.05550892603656e-12 10 0 0 28 5310 WP2853 Endoderm Differentiation 1.00000000000607 6.06815451081521e-12 145 0 0 28 5310 WP1449 Regulation of toll-like receptor signaling pathway 1.00000000000607 6.06815451081521e-12 145 0 0 28 5310 WP2865 IL1 and megakaryocytes in obesity 1.00000000000613 6.1319115659527e-12 25 0 0 28 5310 WP3668 Hypothesized Pathways in Pathogenesis of Cardiovascular Disease 1.00000000000613 6.1319115659527e-12 25 0 0 28 5310 WP2895 Differentiation of white and brown adipocyte 1.00000000000613 6.1319115659527e-12 25 0 0 28 5310 WP1455 Serotonin Transporter Activity 1.00000000000645 6.45277119249032e-12 11 0 0 28 5310 WP2854 Gene regulatory network modelling somitogenesis 1.00000000000645 6.45277119249032e-12 11 0 0 28 5310 WP80 Nucleotide GPCRs 1.00000000000645 6.45277119249032e-12 11 0 0 28 5310 WP2513 Nanoparticle triggered regulated necrosis 1.00000000000645 6.45277119249032e-12 11 0 0 28 5310 WP3630 NAD metabolism, sirtuins and aging 1.00000000000645 6.45277119249032e-12 11 0 0 28 5310 WP45 G1 to S cell cycle control 1.00000000000654 6.54127874835683e-12 68 0 0 28 5310 WP3303 Rac1/Pak1/p38/MMP-2 pathway 1.00000000000654 6.54127874835683e-12 68 0 0 28 5310 WP2911 miRNA targets in ECM and membrane receptors 1.00000000000716 7.15845045703616e-12 43 0 0 28 5310 WP1433 Nucleotide-binding Oligomerization Domain (NOD) pathway 1.0000000000072 7.19710114977696e-12 41 0 0 28 5310 WP405 Eukaryotic Transcription Initiation 1.00000000000817 8.16588473604098e-12 42 0 0 28 5310 WP466 DNA Replication 1.00000000000817 8.16588473604098e-12 42 0 0 28 5310 WP3584 MECP2 and Associated Rett Syndrome 1.00000000000832 8.32353446289124e-12 62 0 0 28 5310 WP1946 Cori Cycle 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP501 GPCRs, Class C Metabotropic glutamate, pheromone 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP47 Hedgehog Signaling Pathway 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP550 Biogenic Amine Synthesis 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP12 Osteoclast Signaling 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP2291 Deregulation of Rab and Rab Effector Genes in Bladder Cancer 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP3644 NAD+ metabolism 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP2453 TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP53 ID signaling pathway 1.00000000000835 8.34696129339693e-12 16 0 0 28 5310 WP75 Toll-like Receptor Signaling Pathway 1.00000000001009 1.00885495124681e-11 103 0 0 28 5310 WP185 Integrin-mediated Cell Adhesion 1.00000000001009 1.00885495124681e-11 103 0 0 28 5310 WP702 Metapathway biotransformation 1.00000000001009 1.00920255141196e-11 177 0 0 28 5310 WP1984 Integrated Breast Cancer Pathway 1.00000000001018 1.01822448452424e-11 154 0 0 28 5310 WP2446 Retinoblastoma (RB) in Cancer 1.0000000000104 1.0399124661361e-11 88 0 0 28 5310 WP15 Selenium Micronutrient Network 1.00000000001718 1.71777775620828e-11 87 0 0 28 5310